This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tandeep Kaur: Innovator in Anticancer Research
Introduction
Tandeep Kaur is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. His work focuses on synthesizing innovative chemical compounds that exhibit biological activity.
Latest Patents
Tandeep Kaur holds a patent for "Benzylidene indanones and processes for preparation and use thereof." This invention relates to benzylidene indanones of general formula 1, which have shown tubulin polymerization inhibition. A series of compounds, specifically 2-benzylidene 3-(3,4,5-trimethoxyphenyl) indanones, were synthesized from gallic acid through a chemical process. One representative compound, 2-(3,4-Methylenedioxybenzylidine), 3-(3,4,5-trimethoxyphenyl), 4,5,6-trimethoxyindanone (8), exhibits potent anticancer activity. This compound was evaluated for acute oral activity in Swiss albino mice and was found to be safe up to 300 mg/kg body weight. The anticancer activity of these compounds has been determined using an in vitro cytotoxicity assay, aiming to discover new potent and cost-effective molecules.
Career Highlights
Tandeep Kaur is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work has contributed to advancements in the field of cancer treatment, showcasing his dedication to improving healthcare through innovative solutions.
Collaborations
Tandeep has collaborated with notable coworkers, including Arvind Singh Negi and Suaib Luqman. Their combined efforts have furthered research in the development of effective anticancer agents.
Conclusion
Tandeep Kaur's innovative work in synthesizing benzylidene indanones highlights his commitment to advancing medicinal chemistry and cancer research. His contributions are paving the way for new therapeutic options in the fight against cancer.
